163 related articles for article (PubMed ID: 38189037)
1. Treatment With Antitumor Agents Recommended by Cancer Genome Panel for Uterine Leiomyosarcoma.
Hayashi T; Kishimoto N; Abiko K; Konishi I
J Clin Med Res; 2023 Dec; 15(10-11):461-468. PubMed ID: 38189037
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of uterine sarcomas.
Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
[TBL] [Abstract][Full Text] [Related]
3. Uterine leiomyosarcoma: a rare clinical entity.
Dunphy L; Sheridan G
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34433536
[TBL] [Abstract][Full Text] [Related]
4. A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.
Nagamata S; Ebina Y; Yamano Y; Miyamoto T; Nishijima M; Yamada H
Kobe J Med Sci; 2016 Jul; 62(2):E45-8. PubMed ID: 27578036
[TBL] [Abstract][Full Text] [Related]
5. Clinically Aggressive Uterine Epithelioid Leiomyosarcoma with Rhabdomyoblastic Differentiation and High Proliferation Rate: A Case Report.
Kim JY; Kim B
Am J Case Rep; 2023 May; 24():e939349. PubMed ID: 37190674
[TBL] [Abstract][Full Text] [Related]
6. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
Ricci S; Stone RL; Fader AN
Gynecol Oncol; 2017 Apr; 145(1):208-216. PubMed ID: 28209496
[TBL] [Abstract][Full Text] [Related]
7. Systematic chemotherapy for inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a systematic review.
Gupta AA; Yao X; Verma S; Mackay H; Hopkins L;
Clin Oncol (R Coll Radiol); 2013 Jun; 25(6):346-55. PubMed ID: 23295078
[TBL] [Abstract][Full Text] [Related]
8. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
9. [Metastatic lung tumor from uterine leiomyosarcoma].
Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
11. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment for uterine leiomyosarcomas.
Gadducci A; Guerrieri ME
Expert Opin Pharmacother; 2015 Feb; 16(3):335-46. PubMed ID: 25418060
[TBL] [Abstract][Full Text] [Related]
13. Leiomyosarcoma after uterine artery embolization. A case report.
Joyce A; Hessami S; Heller D
J Reprod Med; 2001 Mar; 46(3):278-80. PubMed ID: 11304875
[TBL] [Abstract][Full Text] [Related]
14. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
[TBL] [Abstract][Full Text] [Related]
15. Curcumin targets the AKT-mTOR pathway for uterine leiomyosarcoma tumor growth suppression.
Wong TF; Takeda T; Li B; Tsuiji K; Kondo A; Tadakawa M; Nagase S; Yaegashi N
Int J Clin Oncol; 2014 Apr; 19(2):354-63. PubMed ID: 23666561
[TBL] [Abstract][Full Text] [Related]
16. The role of adjuvant therapy in uterine leiomyosarcoma.
Ducie JA; Leitao MM
Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647
[TBL] [Abstract][Full Text] [Related]
17. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING UTERINE LEIOMYOSARCOMA.
Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
[TBL] [Abstract][Full Text] [Related]
18. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
19. [Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups].
Collineau B; Genestie C; Croce S; Meeus P; Floquet A; Guyon F; Llacer-Moscardo C; Lebreton C; Taieb S; Toulmonde M; Blay JY; Bonvalot S; Ray-Coquard I; Pautier P; Duffaud F
Bull Cancer; 2023 Apr; 110(4):440-449. PubMed ID: 36863922
[TBL] [Abstract][Full Text] [Related]
20. Uterine leiomyosarcoma well-controlled with eribulin mesylate.
Fujimoto E; Takehara K; Tanaka T; Yokoyama T; Tomono K; Okazawa-Sakai M; Okame S; Sugawara Y; Teramoto N
Int Cancer Conf J; 2019 Jan; 8(1):33-38. PubMed ID: 31149544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]